News Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 17, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the 10th...
-
Feb 25, 2015Monovisc® Receives Unique J-Code Assignment from CMS Effective January 1, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today reported...
-
Feb 19, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has appointed Glenn R. Larsen, Ph.D., as a new independent member of its Board of Directors. Dr....
-
Feb 12, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its fourth-quarter and year-end 2014 financial results after the close of the market on
-
Feb 11, 2015
BEDFORD, Mass--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (HA) technology, today announced...
-
Nov 10, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that the Center for Medicare & Medicaid Services ("CMS") has assigned a unique Healthcare Common Procedure...
-
Oct 29, 2014Earnings per Share Increase to $0.40 from $0.33
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (HA) technology, today reported...
-
Oct 16, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its third-quarter 2014 financial results after the close of the market on...
-
Aug 4, 2014Presentation to be Webcast Live at 10:30 a.m. ET
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the...
-
Jul 30, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has entered into a new agreement with Medline Industries, Inc. to commercialize the Company's...
-
Jul 30, 2014Total Revenue Grows 26% to $26.3 Million
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (HA) technology, today reported...
-
Jul 15, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its second-quarter 2014 financial results after the close of the market on...
-
Apr 29, 2014Receives $17.5 Million in Monovisc® Milestone Payment
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today...
-
Apr 16, 2014
BEDFORD, Mass--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2014 financial results after the close of the market on Tuesday,...
-
Apr 15, 2014Company's Commercial Partner, DePuy Synthes Mitek Sports Medicine, Records First Commercial Sale of Single-Injection Treatment for Osteoarthritis Knee Pain
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today...
-
Mar 13, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today...
-
Mar 4, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the 9th...
-
Feb 26, 2014Monovisc® Achieves FDA Approval
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today...
-
Feb 25, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced it has received marketing approval for MONOVISC® from the U.S. Food and Drug Administration (FDA)....
-
Feb 12, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its fourth-quarter and year-end 2013 financial results after the close of the market on
-
Jan 9, 2014
Anika Therapeutics to Present at the Tenth Annual Noble Financial Equity Conference on January 20 BEDFORD, Mass. --(BUSINESS WIRE)--Jan. 9, 2014-- Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader...
-
Oct 30, 2013TOTAL REVENUE GROWS TO $17.8 MILLION
BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 30, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”)...
-
Oct 15, 2013
Anika Therapeutics Announces Date of Third-Quarter 2013 Financial Results Conference Call BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 15, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced...
-
Oct 2, 2013
Anika Therapeutics Appoints Industry-Recognized R&D Executive John W. Sheets, Jr., Ph.D. as Chief Scientific Officer BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 2, 2013-- Anika Therapeutics, Inc....
-
Aug 16, 2013
Anika Therapeutics to Present at the Rodman & Renshaw Annual Global Investment Conference on September 10 BEDFORD, Mass. --(BUSINESS WIRE)--Aug. 16, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK)...